2015_annex_3.pdf
(1.55 MB, PDF)
… S., Monsch, A., Nobili, F., Nordberg, A., Rikkert, M.O., Orgogozo, J.M., Pasquier, F., Peters, O., Salmon, E., Sanchez-Castellano, C., Santana, I., Sarazin, M., Traykov, L., Tsolaki, M., Visser, P.J., Wallin, A.K., Wilcock, G., Wilkinson, D., Wolf, H., Yener, G., Zekry, D., and Frisoni, G.B., The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey. Alzheimers Dement, 2015. 11(2): p. 195-206 e1. [IF 12,407] 20. Boots, L.M., Wolfs, C.A., Verhey, F.R., Kempen, G.I., and de Vugt, M.E., Qualitative study on needs and wishes of early-stage dementia caregivers: the paradox between needing and accepting help. Int Psychogeriatr, 2015. 27(6): p. 927-36.[IF 1,934] 21. Borst, J., … Domain II S4-S5 Linker in Nav1.9: A Missense Mutation Enhances Activation, Impairs Fast Inactivation, and Produces Human Painful Neuropathy. Neuromolecular Med, 2015. 17(2): p. 158-69.[IF 3,678] 62. Handels, R.L., Joore, M.A., Tran-Duy, A., Wimo, A., Wolfs, C.A., Verhey, F.R., and Severens, J.L., Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment decision in mild cognitive impairment. Alzheimers Dement, …